Skip to main content

Table 2 Clinical outcomes of patients according to routes of PPI

From: Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy

 

ESO (n = 50)

LAN (n = 50)

Recurrent bleeding (%)#

2 (4%)

2 (4%)

Hospital stay (days, s.e.m.)#*

3.9 (0.2)

1.8(0.3)

Volume of blood transfusion (ml, s.e.m.)

781 (145)

520 (101)

Surgery (%)

0 (0%)

0 (0%)

Death (%)

0 (0%)

0 (0%)

  1. #Numerical variables expressed as mean with standard error of mean (s.e.m.)
  2. *Hospital stay: p > 0.001 between both groups, others: p > 0.1.